JPMorgan raised the firm’s price target on Fresenius Medical to EUR 38 from EUR 28.60 and keeps an Underweight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on FMS:
- Fresenius Medical resumed with a Neutral at Citi
- Fresenius Medical price target raised to $28 from $26 at Truist
- Fresenius Medical initiated with a Buy at Goldman Sachs
- Fresenius Medical names Martin Fischer as CFO, succeeding Helen Giza
- CMS proposes 1.6% payment increase for dialysis operators in 2024